Bruker Corporation $BRKR Position Boosted by Wealth Enhancement Advisory Services LLC

Key Points

• Wealth Enhancement Advisory Services LLC increased its holdings in Bruker Corporation by 35.6% during the second quarter, now owning 40,450 shares valued at approximately $1.7 million.
• Bruker reported a net margin of 2.31% and revenue of $797.4 million for the last quarter, missing analyst estimates.
• The company announced a quarterly dividend of $0.05, representing an annualized yield of 0.6%, with a dividend payout ratio of 38.46%.

Wealth Enhancement Advisory Services LLC raised its holdings in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 35.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,450 shares of the medical research company's stock after acquiring an additional 10,624 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Bruker were worth $1,717,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Teacher Retirement System of Texas grew its stake in Bruker by 5.1% during the 1st quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock valued at $1,212,000 after acquiring an additional 1,422 shares in the last quarter. Fifth Third Bancorp increased its holdings in Bruker by 54.2% in the first quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock worth $46,000 after buying an additional 390 shares during the last quarter. Amundi increased its holdings in Bruker by 373.3% in the first quarter. Amundi now owns 42,503 shares of the medical research company's stock worth $1,774,000 after buying an additional 33,522 shares during the last quarter. OneDigital Investment Advisors LLC boosted its position in Bruker by 38.0% during the first quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock worth $230,000 after purchasing an additional 1,520 shares during the period. Finally, Advisors Capital Management LLC boosted its position in shares of Bruker by 12.0% in the first quarter. Advisors Capital Management LLC now owns 81,425 shares of the medical research company's stock valued at $3,399,000 after acquiring an additional 8,745 shares during the period. Hedge funds and other institutional investors own 79.52% of the company's stock.

Bruker Price Performance

Shares of BRKR stock opened at $30.88 on Tuesday. The stock has a 50-day moving average price of $33.95 and a 200 day moving average price of $37.73. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. The firm has a market cap of $4.69 billion, a price-to-earnings ratio of 59.39, a PEG ratio of 4.32 and a beta of 1.22. Bruker Corporation has a 12 month low of $28.53 and a 12 month high of $70.38.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). The firm had revenue of $797.40 million during the quarter, compared to analyst estimates of $811.17 million. Bruker had a return on equity of 17.89% and a net margin of 2.31%.Bruker's revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.52 earnings per share. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Research analysts expect that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 3rd. Investors of record on Tuesday, September 23rd will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, September 23rd. Bruker's dividend payout ratio (DPR) is presently 38.46%.

Insider Buying and Selling

In related news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $32.25, for a total value of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares in the company, valued at $581,016. This trade represents a 16.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 27.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

BRKR has been the subject of several research reports. Jefferies Financial Group set a $60.00 price objective on Bruker and gave the company a "buy" rating in a research report on Monday, August 4th. Stifel Nicolaus set a $40.00 price objective on Bruker and gave the company a "hold" rating in a research report on Tuesday, August 5th. Citigroup reduced their price objective on Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. Barclays reduced their price objective on Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Wells Fargo & Company reduced their price objective on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $51.30.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.